FindTrial
Sign In

An Open-Label Randomized Trial Evaluating the Efficacy of Levobupivacaine and Ropivacaine with Dexmedetomidine for Ultrasound-Guided Brachial Plexus Block in Upper Limb Surgery

Efficacy of 0.5 percent Levobupivacaine with 50 microgram of Dexmedetomidine and 0.5 percent Ropivacaine with 50 microgram of Dexmedetomidine for Ultrasound guided Brachial plexus block in patients undergoing upper limb surgeries in tertiary care center.- An open Label randomized control study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079894
Enrollment
90
Registered
2025-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: V299- Motorcycle rider (driver) (passenger) injured in unspecified traffic accident

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Tamilmani J
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Consent to participate 2.Age: 18-65 years 3. Patients with ASA status 1 & 2, Planned for elective upper limb surgery with regional anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with infection at the site of block 2. Patients with coagulation disorder.

Design outcomes

Primary

MeasureTime frame
Onset and duration of sensory and motor blockadeTimepoint: At 2 minutes, 4 minutes, 6 minutes , 8 minutes ,10 minutes ,15 minutes , 20 minutes , 25 minutes and 30 minutes—

Secondary

MeasureTime frame
Hemodynamic stability during surgery Postoperative pain scores. Timepoint: Pain scores at 6 hours, 12 hours & 24 hours—

Countries

India

Contacts

Public ContactDr Tamilmani J

Karpaga Vinayaga Institute of Medical Sciences and Research centre

dr.manoth@gmail.com8903032609

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026